News and Trends 29 Nov 2022Touchlight receives new grant to further develop doggybone DNA vaccine platform UK-based biotechnology company, Touchlight, has received a new grant from the Bill & Melinda Gates Foundation. The company will use… November 29, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 30 Aug 2022Bactolife receives $5M in new funding to address gut infections worldwide Bactolife has received an investment of $5 million from The Bill & Melinda Gates Foundation to accelerate the use of… August 30, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jul 2022First patient receives new immunotherapy drug for HIV in clinical trial A new class of bispecific protein immunotherapy, being developed for patients with human immunodeficiency virus (HIV) infection, has been given… July 12, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jul 2021British Diagnostics Biotech Becomes Social Enterprise After Acquisition UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by a group of philanthropic funds… July 30, 2021 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
More News! 29 Nov 2019MedinCell Granted €17M to Develop Cheap Long-Acting Contraception The French company MedinCell has received a €17.3M ($19M) grant from the Bill and Melinda Gates Foundation to advance its… November 29, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 12 Jun 2019Evotec to Reduce the Burden of Tuberculosis Treatment with €21M Grant The Bill and Melinda Gates Foundation has granted the German biotech Evotec €21M ($23.8M) to discover drug combinations that can… June 12, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jul 2017German Biotech Publishes First-in-Human Data on Rabies mRNA Vaccine CureVac has published proof-of-concept data for an mRNA rabies vaccine that could open the door for a new generation of… July 26, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 1 Dec 2016UPDATE: The HIV Frontier starts Phase III Vaccine trials in South Africa Update (01/12/2016): The HVTN 702 trial has been started, making it the first HIV vaccine efficacy study in 7 years… December 1, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jun 2016Gates Foundation is funding EU Biotech to make Vaccines more affordable Batavia Biosciences has won a €3.3M grant from the Gates Foundation, to fund new research in making cell culture cheaper -… June 10, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 1 Jul 2015mRNA Therapies: CureVac Outperformed the Money Magnet Moderna Everybody has already heard about Boston-based Moderna Therapeutics, the most highly valued venture-backed private Biotech, but CureVac, its German competitor, remains much more understated. This could… July 1, 2015 - 3 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email